Radiation pneumonia (RP) is the most common side effect of chest radiotherapy, and can affect patients' quality of life. This study aimed to establish a combined model of radiomics, dosiomics, deep learning (DL) based on simulated location CT and dosimetry images combining with clinical parameters to improve the predictive ability of ≥ 2 grade RP (RP2) in patients with non-small cell lung cancer (NSCLC). This study retrospectively collected 245 patients with NSCLC who received radiotherapy from three hospitals. 162 patients from Hospital I were randomly divided into training cohort and internal validation cohort according to 7:3. 83 patients from two other hospitals served as an external validation cohort. Multivariate analysis was used to screen independent clinical predictors and establish clinical model (CM). The radiomic and dosiomics (RD) features and DL features were extracted from simulated location CT and dosimetry images based on the region of interest (ROI) of total lung-PTV (TL-PTV). The features screened by the t-test and least absolute shrinkage and selection operator (LASSO) were used to construct the RD and DL model, and RD-score and DL-score were calculated. RD-score, DL-score and independent clinical features were combined to establish deep learning radiomics and dosiomics nomogram (DLRDN). The model performance was evaluated by area under the curve (AUC). Three clinical factors, including V20, V30, and mean lung dose (MLD), were used to establish the CM. 7 RD features including 4 radiomics features and 3 dosiomics features were selected to establish RD model. 10 DL features were selected to establish DL model. Among the different models, DLRDN showed the best predictions, with the AUCs of 0.891 (0.826-0.957), 0.825 (0.693-0.957), and 0.801 (0.698-0.904) in the training cohort, internal validation cohort and external validation cohort, respectively. DCA showed that DLRDN had a higher overall net benefit than other models. The calibration curve showed that the predicted value of DLRDN was in good agreement with the actual value. Overall, radiomics, dosiomics, and DL features based on simulated location CT and dosimetry images have the potential to help predict RP2. The combination of multi-dimensional data produced the optimal predictive model, which could provide guidance for clinicians.

To investigate lung changes in patients with polymyositis/dermatomyositis-associated interstitial lung disease (PM/DM-ILD) using quantitative CT and to construct a diagnostic model to evaluate the application of quantitative CT and machine learning in diagnosing PM/DM-ILD. Chest CT images from 348 PM/DM individuals were quantitatively analyzed to obtain the lung volume (LV), mean lung density (MLD), and intrapulmonary vascular volume (IPVV) of the whole lung and each lung lobe. The percentage of high attenuation area (HAA %) was determined using the lung density histogram. Patients hospitalized from 2016 to 2021 were used as the training set (n=258), and from 2022 to 2023 were used as the temporal test set (n=90). Seven classification models were established, and their performance was evaluated through ROC analysis, decision curve analysis, calibration, and precision-recall curve. The optimal model was selected and interpreted with Python's SHAP model interpretation package. Compared to the non-ILD group, the mean lung density and percentage of high attenuation area in the whole lung and each lung lobe were significantly increased, and the lung volume and intrapulmonary vessel volume were significantly decreased in the ILD group. The Random Forest (RF) model demonstrated superior performance with the test set area under the curve of 0.843 (95% CI: 0.821-0.865), accuracy of 0.778, sensitivity of 0.784, and specificity of 0.750. Quantitative CT serves as an objective and precise method to assess pulmonary changes in PM/DM-ILD patients. The RF model based on CT quantitative parameters displayed strong diagnostic efficiency in identifying ILD, offering a new and convenient approach for evaluating and diagnosing PM/DM-ILD patients.

Trauma-induced rib fractures are a common injury. The number and characteristics of these fractures influence whether a patient is treated nonoperatively or surgically. Rib fractures are typically diagnosed using CT scans, yet 19.2-26.8% of fractures are still missed during assessment. Another challenge in managing rib fractures is the interobserver variability in their classification. Purpose of this study was to develop and assess an automated method that detects rib fractures in CT scans, and classifies them according to the Chest Wall Injury Society (CWIS) classification. 198 CT scans were collected, of which 170 were used for training and internal validation, and 28 for external validation. Fractures and their classifications were manually annotated in each of the scans. A detection and classification network was trained for each of the three components of the CWIS classifications. In addition, a rib number labeling network was trained for obtaining the rib number of a fracture. Experiments were performed to assess the method performance. On the internal test set, the method achieved a detection sensitivity of 80%, at a precision of 87%, and an F1-score of 83%, with a mean number of FPPS (false positives per scan) of 1.11. Classification sensitivity varied, with the lowest being 25% for complex fractures and the highest being 97% for posterior fractures. The correct rib number was assigned to 94% of the detected fractures. The custom-trained nnU-Net correctly labeled 95.5% of all ribs and 98.4% of fractured ribs in 30 patients. The detection and classification performance on the external validation dataset was slightly better, with a fracture detection sensitivity of 84%, precision of 85%, F1-score of 84%, FPPS of 0.96 and 95% of the fractures were assigned the correct rib number. The method developed is able to accurately detect and classify rib fractures in CT scans, there is room for improvement in the (rare and) underrepresented classes in the training set.

Severe respiratory infections pose a major challenge in clinical practice, especially in older adults. Body composition analysis could play a crucial role in risk assessment and therapeutic decision-making. This study investigates whether obesity or sarcopenia has a greater impact on mortality in patients with severe respiratory infections. The study focuses on the National Pandemic Cohort Network (NAPKON-SUEP) cohort, which includes patients over 60 years of age with confirmed severe COVID-19 pneumonia. An innovative approach was adopted, using pre-trained deep learning models for automated analysis of body composition based on routine thoracic CT scans. The study included 157 hospitalized patients (mean age 70 ± 8 years, 41% women, mortality rate 39%) from the NAPKON-SUEP cohort at 57 study sites. A pre-trained deep learning model was used to analyze body composition (muscle, bone, fat, and intramuscular fat volumes) from thoracic CT images of the NAPKON-SUEP cohort. Binary logistic regression was performed to investigate the association between obesity, sarcopenia, and mortality. Non-survivors exhibited lower muscle volume (p = 0.043), higher intramuscular fat volume (p = 0.041), and a higher BMI (p = 0.031) compared to survivors. Among all body composition parameters, muscle volume adjusted to weight was the strongest predictor of mortality in the logistic regression model, even after adjusting for factors such as sex, age, diabetes, chronic lung disease and chronic kidney disease, (odds ratio = 0.516). In contrast, BMI did not show significant differences after adjustment for comorbidities. This study identifies muscle volume derived from routine CT scans as a major predictor of survival in patients with severe respiratory infections. The results underscore the potential of AI supported CT-based body composition analysis for risk stratification and clinical decision making, not only for COVID-19 patients but also for all patients over 60 years of age with severe acute respiratory infections. The innovative application of pre-trained deep learning models opens up new possibilities for automated and standardized assessment in clinical practice.

Foundation models, pretrained on extensive datasets, have significantly advanced machine learning by providing robust and transferable embeddings applicable to various domains, including medical imaging diagnostics. This study evaluates the utility of embeddings derived from both general-purpose and medical domain-specific foundation models for training lightweight adapter models in multi-class radiography classification, focusing specifically on tube placement assessment. A dataset comprising 8842 radiographs classified into seven distinct categories was employed to extract embeddings using six foundation models: DenseNet121, BiomedCLIP, Med-Flamingo, MedImageInsight, Rad-DINO, and CXR-Foundation. Adapter models were subsequently trained using classical machine learning algorithms. Among these combinations, MedImageInsight embeddings paired with an support vector machine adapter yielded the highest mean area under the curve (mAUC) at 93.8%, followed closely by Rad-DINO (91.1%) and CXR-Foundation (89.0%). In comparison, BiomedCLIP and DenseNet121 exhibited moderate performance with mAUC scores of 83.0% and 81.8%, respectively, whereas Med-Flamingo delivered the lowest performance at 75.1%. Notably, most adapter models demonstrated computational efficiency, achieving training within one minute and inference within seconds on CPU, underscoring their practicality for clinical applications. Furthermore, fairness analyses on adapters trained on MedImageInsight-derived embeddings indicated minimal disparities, with gender differences in performance within 2% and standard deviations across age groups not exceeding 3%. These findings confirm that foundation model embeddings-especially those from MedImageInsight-facilitate accurate, computationally efficient, and equitable diagnostic classification using lightweight adapters for radiographic image analysis.

The automatic diagnosis of chest diseases is a popular and challenging task. Most current methods are based on convolutional neural networks (CNNs), which focus on local features while neglecting global features. Recently, self-attention mechanisms have been introduced into the field of computer vision, demonstrating superior performance. Therefore, this paper proposes an effective model, CheX-DS, for classifying long-tail multi-label data in the medical field of chest X-rays. The model is based on the excellent CNN model DenseNet for medical imaging and the newly popular Swin Transformer model, utilizing ensemble deep learning techniques to combine the two models and leverage the advantages of both CNNs and Transformers. The loss function of CheX-DS combines weighted binary cross-entropy loss with asymmetric loss, effectively addressing the issue of data imbalance. The NIH ChestX-ray14 dataset is selected to evaluate the model's effectiveness. The model outperforms previous studies with an excellent average AUC score of 83.76\%, demonstrating its superior performance.

Radiogenomics holds promise in identifying molecular alterations in nonsmall cell lung cancer (NSCLC) using imaging features. Previously, we developed a radiogenomics model to predict epidermal growth factor receptor (EGFR) mutations based on contrast-enhanced computed tomography (CECT) in NSCLC patients. The current study aimed to externally validate this model using a publicly available National Institutes of Health (NIH)-based NSCLC dataset and assess the effect of EGFR mutation prevalence on model performance through synthetic minority oversampling technique (SMOTE). The original radiogenomics model was validated on an independent NIH cohort (n=140). For assessing the influence of disease prevalence, six SMOTE-augmented datasets were created, simulating EGFR mutation prevalence from 25% to 50%. Seven models were developed (one from original data, six SMOTE-augmented), each undergoing rigorous cross-validation, feature selection, and logistic regression modeling. Models were tested against the NIH cohort. Performance was compared using area under the receiver operating characteristic curve (Area Under the Curve [AUC]), and differences between radiomic-only, clinical-only, and combined models were statistically assessed. External validation revealed poor diagnostic performance for both our model and a previously published EGFR radiomics model (AUC ∼0.5). The clinical model alone achieved higher diagnostic accuracy (AUC 0.74). SMOTE-augmented models showed increased sensitivity but did not improve overall AUC compared to the clinical-only model. Changing EGFR mutation prevalence had minimal impact on AUC, challenging previous assumptions about the influence of sample imbalance on model performance. External validation failed to reproduce prior radiogenomics model performance, while clinical variables alone retained strong predictive value. SMOTE-based oversampling did not improve diagnostic accuracy, suggesting that, in EGFR prediction, radiomics may offer limited value beyond clinical data. Emphasis on robust external validation and data-sharing is essential for future clinical implementation of radiogenomic models.

Chronic obstructive pulmonary disease (COPD) is a common and progressive respiratory condition characterized by persistent airflow limitation and symptoms such as dyspnea, cough, and sputum production. Acute exacerbations (AE) of COPD (AE-COPD) are key determinants of disease progression; yet, existing predictive models relying mainly on spirometric measurements, such as forced expiratory volume in 1 second, reflect only a fraction of the physiological information embedded in respiratory function tests. Recent advances in artificial intelligence (AI) have enabled more sophisticated analyses of full spirometric curves, including flow-volume loops and volume-time curves, facilitating the identification of complex patterns associated with increased exacerbation risk. This study aimed to determine whether a predictive model that integrates clinical data and spirometry images with the use of AI improves accuracy in predicting moderate-to-severe and severe AE-COPD events compared to a clinical-only model. A retrospective cohort study was conducted using COPD registry data from 2 teaching hospitals from January 2004 to December 2020. The study included a total of 10,492 COPD cases, divided into a development cohort (6870 cases) and an external validation cohort (3622 cases). The AI-enhanced model (AI-PFT-Clin) used a combination of clinical variables (eg, history of AE-COPD, dyspnea, and inhaled treatments) and spirometry image data (flow-volume loop and volume-time curves). In contrast, the Clin model used only clinical variables. The primary outcomes were moderate-to-severe and severe AE-COPD events within a year of spirometry. In the external validation cohort, the AI-PFT-Clin model outperformed the Clin model, showing an area under the receiver operating characteristic curve of 0.755 versus 0.730 (P<.05) for moderate-to-severe AE-COPD and 0.713 versus 0.675 (P<.05) for severe AE-COPD. The AI-PFT-Clin model demonstrated reliable predictive capability across subgroups, including younger patients and those without previous exacerbations. Higher AI-PFT-Clin scores correlated with elevated AE-COPD risk (adjusted hazard ratio for Q4 vs Q1: 4.21, P<.001), with sustained predictive stability over a 10-year follow-up period. The AI-PFT-Clin model, by integrating clinical data with spirometry images, offers enhanced predictive accuracy for AE-COPD events compared to a clinical-only approach. This AI-based framework facilitates the early identification of high-risk individuals through the detection of physiological abnormalities not captured by conventional metrics. The model's robust performance and long-term predictive stability suggest its potential utility in proactive COPD management and personalized intervention planning. These findings highlight the promise of incorporating advanced AI techniques into routine COPD management, particularly in populations traditionally seen as lower risk, supporting improved management of COPD through tailored patient care.

We introduce CheXGenBench, a rigorous and multifaceted evaluation framework for synthetic chest radiograph generation that simultaneously assesses fidelity, privacy risks, and clinical utility across state-of-the-art text-to-image generative models. Despite rapid advancements in generative AI for real-world imagery, medical domain evaluations have been hindered by methodological inconsistencies, outdated architectural comparisons, and disconnected assessment criteria that rarely address the practical clinical value of synthetic samples. CheXGenBench overcomes these limitations through standardised data partitioning and a unified evaluation protocol comprising over 20 quantitative metrics that systematically analyse generation quality, potential privacy vulnerabilities, and downstream clinical applicability across 11 leading text-to-image architectures. Our results reveal critical inefficiencies in the existing evaluation protocols, particularly in assessing generative fidelity, leading to inconsistent and uninformative comparisons. Our framework establishes a standardised benchmark for the medical AI community, enabling objective and reproducible comparisons while facilitating seamless integration of both existing and future generative models. Additionally, we release a high-quality, synthetic dataset, SynthCheX-75K, comprising 75K radiographs generated by the top-performing model (Sana 0.6B) in our benchmark to support further research in this critical domain. Through CheXGenBench, we establish a new state-of-the-art and release our framework, models, and SynthCheX-75K dataset at https://raman1121.github.io/CheXGenBench/

Artificial intelligence (AI) has transformed medical diagnostics by enhancing the accuracy of disease detection, particularly through deep learning models to analyze medical imaging data. However, the energy demands of training these models, such as ResNet and MobileNet, are substantial and often overlooked; however, researchers mainly focus on improving model accuracy. This study compares the energy use of these two models for classifying thoracic diseases using the well-known CheXpert dataset. We calculate power and energy consumption during training using the EnergyEfficientAI library. Results demonstrate that MobileNet outperforms ResNet by consuming less power and completing training faster, resulting in lower overall energy costs. This study highlights the importance of prioritizing energy efficiency in AI model development, promoting sustainable, eco-friendly approaches to advance medical diagnosis.